In tumor cells, the isoprenoid pathway is dysregulated and leads to an accumulation of isopentenyl pyrophosphate (IPP), one of the PAgs, which is recognized by BTN2A1–BTN3A1 [247,248]. This evidence concerns the gene BTN2A1 and neoplasm.